Designed for the comprehensive ophthalmologist, the hot topics symposium featured a series of talks on emerging trends, technologies and therapies across ophthalmology.
A review of the most common legal issues facing small practices today and how to minimize exposure in areas such as employment discrimination, wage hour violations, discipline and termination, confidentiality, privacy and social media use.
A new study presented at AAO 2024 shows that patients treated monthly with an investigational drug ANX007 (Annexon Biosciences) cut their risk of vision loss by 72%.
The 3-physician panel addressed the place of new innovations in the decision tree, how to get started in MIGS, the most anticipated new tools and the importance of listening to your gut.
Peter K. Kaiser, MD, and Diana Do, MD, discuss 3-year data from the PHOTON trial for diabetic macular edema at the 2024 American Academy of Ophthalmology meeting.